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TTC values for chemicals with unknown toxicity but known structure are derived from 5th percentiles of
NOAEL distributions from compounds with known toxicity. The impact of chemical structures on TTC val-
ues was repeatedly investigated but not the impact of parameters such as study numbers per compound
and differences in study design. Recently, study design parameters such as application route with related
dose-decrements, dose-spacing and number of animals per group but not exposure duration were found
to affect NOAEL distributions. Here, the impact of study design parameters on lowest NOAEL distributions
and consequently on TTC values was analyzed in a database on 423 Cramer class III pesticides. Using
NOAELs related to lowest LOAELs instead of lowest NOAELs, excluding studies with a dose spacing >8,
and standardizing NOAELs to the initial dose animals received shifted the 5th percentile of NOAEL
distributions from 0.22 to 0.5 mg/kg body weight per day. In contrast, weighting of NOAELs for the study
numbers per compound shifts 5th percentiles downwards to lower values by 10–20%. The results show
that database and study design parameters inﬂuence NOAEL distributions to a minor degree and derived
TTC values therefore can be considered reliable in that perspective.
 2015 Elsevier Inc. All rights reserved.1. Introduction
In the regulatory dietary risk assessment of chemicals
(FAO/WHO, 2009), authorities compare the dietary exposure of a
chemical in question with the chemical-speciﬁc health based guid-
ance value (HBGV) such as Acceptable Daily Intake (ADI), Tolerable
Daily Intake (TDI) and others to identify possible health risks.
HBGV typically are derived from No Observed Adverse Effect
Levels (NOAEL) identiﬁed in laboratory animal studies by using
safety factors that account for several aspects of the underlying
database. There are situations however, where few or no toxicolog-
ical studies are available but the chemical structure of a compound
is known. In such a situation the Toxicological Threshold of
Concern concept (TTC), initially developed by Munro (Munro
et al., 1996) based on Cramer’s grouping of chemicals (Cramer
et al., 1978) offers a scientiﬁcally justiﬁed, pragmatic assessment
tool (EFSA, 2012) which is applied by authorities worldwide
(Bruschweiler, 2014). Over the last two decades, using thetoxicological data provided over several decades, the TTC concept
was constantly reﬁned. Improvements came from databases on
new substances with further toxicological data and reconsidera-
tions of the Cramer classiﬁcations (Bhatia et al., 2015;
Feigenbaum et al., 2015; Galloway et al., 2013; Kalkhof et al.,
2012; Kroes et al., 2004; Laufersweiler et al., 2012; Leeman et al.,
2014; Pinalli et al., 2011; Tluczkiewicz et al., 2011; van
Ravenzwaay et al., 2011, 2012). For several chemical regulatory
ﬁelds, adapted TTC approaches were proposed (Kroes et al., 2007;
Melching-Kollmuss et al., 2010; Muller et al., 2006). The TTC con-
cept assumes that NOAELs of groups of chemical structures scatter
according to deﬁned distributions. Therefore, chemical group
speciﬁc lowest NOAEL distributions allow to calculate exposure
thresholds that should not be exceeded by a compound of
unknown toxicity but known structure to warrant safety with a
certain probability, e.g. 95%, (EFSA, 2012; Munro et al., 1996).
If regulatory measures for a structurally deﬁned population of
chemicals are based on a lowest NOAEL distribution derived from
a sample out of this population, it has to be representative for
the population in question. In the development of the TTC concept,
this point was the subject of intensive investigations on the rela-
tion between chemical structure and NOAEL. However, signiﬁcant
overlap of lowest NOAEL distributions for different chemical
Table 1
Reference database (PSMTOXDB) and data-subset extracts of lowest NOAELs used.
Subset Weighted
(w)
Selection criteria
NO Organophosphates and carbamates (O)
N Nw Compounds including O
Ns Nsw Standardized NOAEL
N8 N8w Dose spacing 68
N8s N8sw Dose spacing 68, standardized NOAEL
NnO NnOw Compounds without O
NnOs NnOsw Standardized NOAEL
N8nO N8nOw Dose spacing 68
N8nOs N8nOsw Dose spacing 68, standardized NOAEL
N-LnO N-LnOw NOAEL related to lowest LOAEL, without O
N-LnOs N-LnOsw Standardized NOAEL
N-L8nO N-L8nOw NOAEL related to lowest LOAEL, without O,
dose spacing 68
N-L8nOs N-L8nOsw Standardized NOAEL
NnOallspec Compounds without O, studies in all 4
species
N4nO Dose spacing 64
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cates that current grouping still does not discriminates satisfacto-
rily. Several publications (Bhatia et al., 2015; Dekant et al., 2010;
Kroes et al., 2004, 2007; Muller et al., 2006; Tluczkiewicz et al.,
2011) address toxicological endpoint-driven and/or chemical
structure driven attempts to divide the world of chemicals into
groups represented by satisfactorily discernible lowest NOAEL dis-
tributions. Further efforts in this direction might improve the con-
cept. However, considerations on the design and quality of the
toxicological studies and the extent of the database per compound
as well as of the sample group representing the population of
chemicals in question should likewise supplement the aspect of
structure–activity relationship in the TTC concept.
In regulatory risk assessment concepts it is assumed that toxi-
cological threshold doses in tested species exist for
non-genotoxic compounds and that they can be approximated by
animal studies. A series of laboratory animal studies is conducted
allowing for potentially changing sensitivities during lifetime
including the pre-natal phase because for a given compound the
exact toxicological mechanism of action and the potency often is
unknown. If several species are tested for a comprehensive range
of toxicological endpoints in a scientiﬁcally sound way, the lowest
NOAEL achieved is considered an appropriate approximation for
the overall lowest toxicological threshold in the tested species.
Hence, it seems self-evident that for a given compound the prox-
imity of the NOAEL to the lowest toxicological threshold depends
on the design of the individual toxicological studies and the
extent/magnitude of the database available for the compound of
interest. For example, the number of species investigated, the
number of studies performed, the animals used per dose group
and the tested dose intervals (dose spacing) are crucial to achieve
closest approximation of the lowest toxicological threshold by the
NOAEL. If regulatory decisions are derived from distributions of
lowest NOAELs, e.g. the use of the TTC concept, and because the
quality of the database for each individual NOAEL entering the
lowest NOAEL distribution has an impact on the distribution, study
design and database-related aspects should be considered. If a
compound was only investigated in one study with few animals
per dose group and few endpoints investigated, the respective
NOAEL has more uncertainty regarding its proximity to the toxico-
logical threshold compared to a compound investigated in several
species in a range of studies and therefore with high statistical
power. In principle, a study design with large dose spacing favors
low NOAELs whereas few animals/endpoints favor high NOAELs
relative to the toxicological threshold.
Recent ﬁndings in retrospective analyses of pesticide evalua-
tions have shown that study design parameters such as number
of animals, dose spacing and the dose decrement during growth
of experimental animals observed in many studies signiﬁcantly
inﬂuence NOAEL distributions (Zarn et al., 2010, 2011, 2013).
Study duration however proved not to have a signiﬁcant effect
on NOAEL.
Based on these experiences, the present work focuses on the
inﬂuence of such parameters on lowest NOAEL distributions of
Cramer class III pesticides and quantiﬁes possible consequences
for TTC values derived thereof. It is not the goal of this publication
to propose additional or modiﬁed TTC values.N8nO_lowweight Dose spacing 68, low-weight half of
distribution
N8nO_highweight Dose spacing 6 8, high-weight half of
distribution
NM Compounds including O, Munro’s criteria*
NMnO Compounds without O, Munro’s criteria*
NMun(cl3) Munro Cramer class 3 compounds
NMun(cl3)nO Munro Cramer class 3 compounds without
O
* Criteria described in Munro et al. (1996).2. Methods and database
Publicly available data from PPP evaluations of toxicity studies
from the European Food Safety Authority (EFSA) (EFSA, 2014), the
Joint FAO/WHO Meeting on Pesticide Residues (JMPR) (WHO,
2011) and the US EPA (US EPA, 2011) were entered into a
Microsoft Ofﬁce Access 2007 database (Zarn et al., 2011). For agiven study, these data included the chemical class of the com-
pound, the number of animals per group and sex, the study dura-
tion, the application route, all dose levels and the NOAEL and the
LOAEL as reported by the evaluating authority. Rat, mouse, rabbit
and dog studies were included if the application route was oral
either by food, drinking water, gavage or capsule administration.
Moreover, information was also included on whether the applica-
tion aimed at constant doses or on constant compound concentra-
tions in food and drinking water and whether constant doses or
constant amounts in gavage and capsule applications were applied.
Only studies providing both an experimental NOAEL and an exper-
imental LOAEL were included. If several studies were found to
result in the same lowest NOAEL, the study with the lowest dose
spacing was chosen. If several studies with equal dose spacing
were found to result in the same lowest NOAEL the study with
the shortest study duration was chosen. All the compounds in
the database were grouped to Cramer classes by Toxtree 2.6.6
(downloaded from http://toxtree.sourceforge.net/index.html) and
only Cramer class III compounds were further used (three com-
pounds were excluded because they were Cramer class II or I).
This reference database PSMTOXDB included 3924 informative
studies from 423 compounds. Further details on the database
and analyses are described elsewhere (Zarn et al., 2011, 2013).
80 (19%, identiﬁed by CAS number) of the compounds in
PSMTOXDB are also included in the Tluczkiewicz database
(Tluczkiewicz et al., 2011), 61 (14%) in the Munro database
(Munro et al., 1996) and an additional 44 (10%) in both. For data
processing and data analyses, Microsoft Ofﬁce Access 2007,
Microsoft Ofﬁce Excel 2007, IBM SPSS Statistics 22 for Windows
and @risk Professional 6.3.1 were used.
To investigate the inﬂuence of several database- (e.g. number of
studies per compound) and study-related features (e.g. dose spac-
ing) on NOAEL distributions, several data subsets were generated
and compared with each other. The data subsets are described
below and a short description of the subsets and their denomina-
tion is given in Table 1.
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As a basis for further data subsets, a subset was created by
excluding organophosphates and carbamates. This was done to
analyze the effect of the highly toxic acetylcholine esterase inhibi-
tors on lowest NOAEL distributions and to make our analyses com-
parable with other published analyses.
Lowest NOAEL distributions where organophosphates and car-
bamates were excluded are designated with ‘‘nO’’.2.2. Restriction of dose spacing
Recently, in analyses on the effect of study duration on
NOAELs, the dose spacing (ratio LOAEL/NOAEL) turned out to
affect NOAEL distributions (Zarn et al., 2010, 2011). It was shown
before that the dose spacing in chronic studies is disproportion-
ately high compared to all other study types. To investigate this
inﬂuence within the context of the current work, a subset exclud-
ing all studies with a dose spacing >8 was created, resulting in
3145 remaining studies for 418 compounds. Chronic studies are
especially prone to high dose spacing ratios. A dose spacing
cut-off value of 8 was chosen, because it excludes a signiﬁcant
fraction of the studies with highest dose spacing but still main-
tains a high amount of chronic studies in the database. To ﬁnd
such an optimal cut-off value, the following procedure was
applied: the fraction of chronic studies remaining in the database
were recorded for each cut-off value between 4 (median dose
spacing for the whole PSMTOXDB) and 12 (only few studies have
a dose-spacing >12), The fraction of chronic studies in the three
subsets NnO (no restriction with regard to dose spacing), N8nO
(only studies with dose spacing 68) and N4nO (only studies with
dose spacing 64) are 62%, 55% and 36% (Table 2), respectively. The
cut-off value of 8 was as the best compromise between exclusion
of studies with high dose spacing and maintenance of a reason-
able fraction of chronic studies. Although 20% of studies with high
dose spacing were hereby excluded the fraction of chronic studies
(7%) lost is considered acceptable.
Lowest NOAEL distributions with dose spacing restrictions are
designated with an ‘‘8’’ in the nomenclature.Table 2
Percentages of study types and species providing the lowest NOAEL in the respective
data subset. Due to rounding, sums of percentages not always add up to 100% (e.g.
studies (only 99%) giving the lowest NOAELs in the N distribution).
Data subset Species Study
Rat Dog Mouse Rabbit c sc sa mg dv
NO 63 31 2 5 39 17 8 17 19
N 52 37 5 6 59 16 4 11 9
Ns 39 45 6 10 44 19 5 15 17
N8 48 36 6 10 52 18 5 11 14
N8s 38 41 6 15 40 18 7 13 22
NnO 52 36 6 6 62 16 3 11 9
NnOs 38 44 7 11 46 18 5 14 16
N8nO 46 38 7 9 55 18 4 10 12
N8nOs 35 43 6 15 43 18 6 12 22
N-LnO 46 37 5 11 57 16 3 10 14
N-LnOs 35 42 7 16 45 20 4 9 21
N-L8nO 44 38 5 12 49 19 5 11 16
N-L8nOs 35 42 7 17 41 21 6 9 23
NnOallspec 53 35 5 6 64 18 2 9 7
N4nO 45 29 8 17 36 20 8 11 25
N8nO_lowweight 50 31 8 11 50 18 6 11 15
N8nO_highweight 43 45 5 8 60 18 3 9 10
NM 87 – 13 – 35 54 1 10 –
NMnO 86 – 14 – 36 53 – 11 –
c, Chronic; sc, subchronic; sa, subacute; mg, multi-generation; dv, developmental.2.3. NOAELs related to lowest LOAELs
As an alternative to investigate and to minimize the inﬂuence of
dose spacing on the NOAEL distributions, not the lowest NOAEL
itself for a given compound was identiﬁed but the NOAEL related
to the lowest LOAEL. This was done because the lowest NOAEL
for a given compound derives not necessarily from the study with
the lowest LOAEL but the latter was the closest approximation of
the toxicological threshold for a substance of interest. If this
approach is combined with restrictions of the database for dose
spacing, NOAEL distributions might result that more accurately
approximate toxicological thresholds than simply selecting for
lowest NOAELs.
NOAEL distributions based on lowest LOAELs are indicated by
‘‘N-L’’ in the nomenclature.
2.4. Standardization method for NOAEL and LOAEL from different
study types
For each study, if applicable, besides the lowest NOAEL and the
lowest LOAEL as reported, also a standardized NOAEL and a stan-
dardized LOAEL was calculated and added to the databases. The
standardization was done for NOAELs of studies with designs
applying the compound either by providing feed with constant
compound concentrations or by capsule or gavage without regular
dose adjustment accounting for decreasing doses as body weights
increase. To make NOAELs and LOAELs from different study designs
and durations better comparable, the NOAELs and LOAELs are stan-
dardized to the initial dose animals received by multiplying
NOAELs and LOAELs with the species and study speciﬁc dose
decrement factors (Table 3). For the present work, dose decrement
factors derived from previous projects were used (Zarn et al., 2010,
2011, 2013).
Lowest NOAEL distributions based on selection of lowest stan-
dardized NOAEL are designated by an ‘‘s’’ in their name.
2.5. Weighting procedure for NOAELs of dataset quality
The toxicity studies required by authorities and submitted by
applicants are very different regarding design and scope between
rat, dog, mouse and rabbit. In rats, fetal developmental,
multi-generation, subchronic and chronic studies are required
and for dogs and mice only subchronic and chronic studies (up
to 2 years). In rabbits, only fetal developmental studies are
required. Additionally, voluntarily the companies also provide
occasionally subacute studies in rat, dog and mouse. In the
PSMTOXDB, the overall median number of studies of any design
per compound is 9 (interquartile range (IQR) 5). The median num-
ber of studies per compound and species is 5 for rats, 2 for dogs, 2
for mice and 1 for rabbits.
To account for the number of informative studies per compound
and the number of species tested, a dataset quality/sensitivity
weighting system was developed. To weight approximately theTable 3
Dose standardization factors for studies with a design not providing constant doses.
This are studies providing feed with constant compound concentrations or by capsule
or gavage without regular dose adjustment accounting for decreasing doses as body
weights increase. Multiplying the reported NOAEL in a study using non-constant
doses by the factors below yields the dose animals were exposed to at the beginning
of the respective study. For example, multiplying a chronic rat feeding study NOAEL
by 2.9 gives the corresponding initial dose.
Subacute Subchronic Chronic
Mouse 1.2 1.3 1.6
Rat 1.6 2.1 2.9
Dog 1.1 1.2 1.4
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requirements for the four species) of the four species considered
in this paper (mouse, rat, rabbit, dog), in the dataset
NnOallspecies (only compounds with at least one informative
study in all four species) the frequencies of the species giving the
lowest NOAEL per compound were identiﬁed. It was found that
the mouse had the lowest frequency for giving the lowest
NOAEL, followed by the rabbit. Rats and dogs nearly had the same
frequency of being the most sensitive species. All species frequen-
cies were standardized to the species with the lowest frequency
(mouse; sensitivity set as 1). This resulted in relative species sen-
sitivities of 10 (rat), 7 (dog) and 1 (mouse and rabbit). For example,
a rat study tenfold more often gave the study with the lowest
NOAEL compared to the mouse. For each compound, these relative
species sensitivity values were then multiplied by the number of
the informative studies per species (1 or 2 or 3 (ifP3 studies avail-
able)) and then summated over the 4 species. The maximum pos-
sible weight value for a compound therefore was 57
(3*10 + 3*7 + 3*1 + 3*1). Since the number of studies and endpoints
covered per species are very different, the species sensitivity factor
as developed above certainly is affected by the number of studies
and the study types performed. Therefore it is important to note
that this approach of weighting probably overestimates the sensi-
tivity of rats (large database per compound) in relation to dogs,
mice and especially rabbits (rather small database per compound).
However, it should be noted that dogs nearly as often as the rats
give the lowest NOAEL for given compounds although fewer stud-
ies with lower statistical power and less endpoints covered are
done in this species.
The resulting distribution of the ‘‘sensitivity’’ factors over all
compounds was grouped into three weight categories. Weight 1
was allocated to compounds with ‘‘sensitivity’’ factors <31, weight
3 to compounds with ‘‘sensitivity’’ factors P31 and 648 and
weight 12 for compounds with ‘‘sensitivity’’ factors >48. The slight
increase in multiples (1, 3, and 12) of weight value factors should
favor in a somewhat balanced way lowest NOAELs of compounds
with an extensive database. The boundaries for the three cate-
gories were allocated based on the distribution of ‘‘sensitivity’’ fac-
tors with the aim to group approximately 10% of the compounds in
the lowest, 70% in the medium and 20% in highest weight class.
In practice, the lowest NOAEL of a compound with a ‘‘sensitiv-
ity’’ factor >48 (therefore weight 12) was used 12-fold and the low-
est NOAEL of a compound with a weighting factor <31 (therefore
weight 1) was used only once in generating a lowest NOAEL
distribution.
It should be noted, although favoring well documented lowest
NOAELs in principle seems scientiﬁcally justiﬁed, there is consider-
able arbitrariness in the factors used.
Lowest NOAEL distributions based on weighted compounds are
designated by the letter ‘‘w’’ in the name.
2.6. Data analyses
To analyze the inﬂuence of dose spacing, dose decrements in
certain study types and data base differences between compounds
on the NOAEL and LOAEL distributions, 5th percentiles of the
cumulative empirical distributions and of appropriate distribution
models were calculated. For each empirical NOAEL and LOAEL dis-
tribution the ratio of the 97.5th and the 2.5th percentiles was cal-
culated. This ratio is an estimate of the range (tightness of
distribution) of NOAELs (and LOAELs) for 95% of compounds in a
given data subset.
All NOAEL distributions were tested for the most appropriate
distributionmodel using @risk Professional 6.3.1. The best ﬁt selec-
tion was done by using Akaike Information Criterion (AIC). In
Table 4 besides the empirical 5th percentiles of the lowestNOAEL distributions also the 5th percentiles of the best ﬁtted
model is given. On the 5th percentile level of the best-ﬁtting mod-
els there was good agreement between the distribution models
and the empirical NOAEL distribution. Unless otherwise stated,
throughout the whole document 5th percentiles of distributions
are referring to the empirical distribution.3. Results and discussion
3.1. PSMTOXDB compared to other databases
Several databases containing partly different substances used
lowest NOAEL distributions for the derivation of TTC values
(Table 5). Among the best known are the Munro database
(Munro et al., 1996) containing among other compounds 437
Cramer class III industrial chemicals, pharmaceuticals, food sub-
stances and environmental, agricultural and consumer chemicals.
The Tluczkiewicz database (Tluczkiewicz et al., 2011) contains
372 Cramer class III compounds compiled from 4 different existing
databases including parts of the Munro database. The Pinalli data-
base (Pinalli et al., 2011) primarily used 113 food contact materials
and the authors derived surrogate NOAELs by multiplying available
TDIs with a presumed default safety factor. The Kalkhof database
(Kalkhof et al., 2012) used subacute and subchronic mouse and
rat studies on 724 industrial chemicals. The Feigenbaum database
(Feigenbaum et al., 2015) includes the NOAELs that were the basis
for the ADIs for 322 pesticides evaluated by the EFSA. The Munro,
Tluczkiewicz and the Kalkhof databases excluded dog studies and
used default time extrapolation factors to yield a presumed chronic
NOAEL from subacute and subchronic NOAELs. The Tluczkiewicz
database additionally excluded developmental and reproductive
studies. The Pinalli and the Feigenbaum databases used TDIs and
ADIs, respectively, and the corresponding NOAELs for their analy-
ses. Information on the species, the study types and the database
were not available.
In summary, not only the databases used for lowest NOAEL dis-
tribution analyses (partly with certain overlaps of compounds
included) by different authors but also the approaches applied in
deriving lowest NOAELs were different. Therefore, the focus of
the present work was on effects of several study design-related
parameters on NOAEL and LOAEL distributions and the derived
percentiles of the distributions. The parameters accounted for were
the dose spacing in studies, time extrapolation factors used for
standardization of NOAELs of different study designs, putative sen-
sitivity differences of different species (related to different data
requirements) and the extent of the underlying database. For this
purpose, data subsets were extracted from PSMTOXDB considered
appropriate to evaluate effects of such study design and database
related effects on NOAEL and LOAEL distributions. The results are
presented and discussed in the following chapters.3.2. PSMTOXDB calibrated to Munro database
Organophosphates and carbamates belong to the most toxic
pesticides and their intended effect, inhibition of the acetyl-
cholinesterase in insects, additionally is also the critical effect (low-
est NOAEL) in the mammalian toxicity proﬁle in the majority of
these compounds. In many analyses on NOAEL distributions these
easy to identify chemical structures were excluded for certain anal-
yses. To make our analyses comparable to other authors’ works, we
also created data subsets without organophosphates and carba-
mates. The 5th percentile in the NOAEL distribution including the
organophosphates and carbamates, N, is 0.06 mg/kg bw per day.
Excluding organophosphates and carbamates (NnO), the 5th
Table 4
Percentiles of cumulative distributions of lowest NOAELs and of NOAELs corresponding to lowest LOAELs. Ratios of 97.5th and 2.5th percentiles were calculated to give an
estimate of the span of the NOAELs for 95% of the distributions. The distribution models were identiﬁed by @risk to best describe the empirical data.
Compounds (number) NOAEL (mg/kg bw per day) LOAEL (mg/kg bw per day)
5th percentile 5th percentile
Distribution Empirical Model Ratio 97.5/2.5 Empirical Ratio 97.5/2.5
NO 59 Levy 0.03 0.02 10613 0.10 632
N 423 Pearson6 0.06 0.08 20661 0.40 739
Nw 423 Pearson6 0.04 0.07 10500 0.22 10045
Ns 423 Pearson6 0.10 0.13 20273 0.73 657
Nsw 423 Pearson6 0.08 0.10 10368 0.36 860
N8 418 Lognormal 0.12 0.16 20703 0.50 730
N8w 418 Pearson6 0.10 0.15 10633 0.31 626
N8s 418 Lognormal 0.20 0.25 20027 0.80 533
N8sw 418 Pearson6 0.14 0.21 10521 0.50 546
NnO 364 Loglogistic 0.22 0.18 924 1.12 268
NnOw 364 Pearson6 0.22 0.18 390 1.00 250
NnOs 364 Loglogistic 0.32 0.30 703 1.55 323
NnOsw 364 Pearson6 0.31 0.30 431 1.40 280
N8nO 362 Pearson6 0.40 0.34 631 1.40 286
N8nOw 362 Pearson6 0.34 0.36 300 1.10 182
N8nOs 362 Lognormal 0.50 0.44 700 1.70 282
N8nOsw 362 Pearson6 0.50 0.52 325 1.50 187
N-LnO 364 Loglogistic 0.28 0.22 10453 1.00 254
N-LnOw 364 Pearson6 0.22 0.23 500 1.00 150
N-LnOs 364 Loglogistic 0.42 0.36 650 1.50 240
N-LnOsw 364 Pearson6 0.37 0.36 664 1.40 170
N-L8nO 362 Pearson6 0.45 0.35 796 1.26 283
N-L8nOw 362 Pearson6 0.40 0.37 324 1.10 142
N-L8nOs 362 Pearson6 0.51 0.54 807 1.70 282
N-L8nOsw 362 Lognormal 0.50 0.68 390 1.50 187
NnOallspec 228 Loglogistic 0.24 0.19 417 1.15 127
N4nO 343 Lognormal 0.50 0.42 936 1.50 384
N8nO_lowweight 181 Lognormal 0.50 0.33 827 1.50 400
N8nO_highweight 181 Loglogistic 0.31 0.30 294 1.39 100
NM 407 lognormal 0.05 0.09 3013 0.43 776
NMnO 350 Lognormal 0.22 0.17 804 1.09 310
NMun(cl3) 437 Lognormal 0.20 0.20 240320
NMun(cl3)nO 410 Lognormal 0.30 0.32 120768
Table 5
Comparison of different databases.
Database Compounds Cramer class III
compounds
Species Studies Prioritization
of studies
Standardization
Munro (Munro et al., 1996) Different
ranges of
application
437 (410 without
organophosphates
and carbamates)
Mice,
rats,
rabbits,
hamsters
Developmental,
reproductive,
subchronic,
chronic
Lowest NOAEL Subchronic NOAELs divided by 3 to give an
anticipated chronic NOAEL
Tluczkiewicz (Tluczkiewicz
et al., 2011)
Different
ranges of
application
372 (without
organophosphates);
compiled from 4
different existing
databases
Mice,
rats
Subacute,
subchronic,
chronic
NOAEL of
study with
longest
duration
Subchronic and subacute NOAELs divided
by 2 and 6 to give an anticipated chronic
NOAEL
Pinalli (Pinalli et al., 2011) Food
contact
materials
113 Not
speciﬁed
Not speciﬁed,
only noted
‘‘typically
90 day oral
studies’’
TDI divided by
100 to give
surrogate
NOAEL
No standardization
Kalkhof (Kalkhof et al., 2012) Industrial
chemicals
724 Mice,
rats
Subacute,
subchronic,
Lowest NOAEL Subchronic and subacute NOAELs divided
by 2 and 6 to give an anticipated chronic
NOAEL
Feigenbaum (Feigenbaum et al.,
2015)
Pesticides 322 (279 without
organophosphates
and carbamates)
Not
speciﬁed
Not speciﬁed NOAEL
reported by
EFSA as basis
for the ADI
No standardization
Present study Pesticides 423 (364 without
organophosphates
and carbamates)
Mice,
rats,
rabbits,
dogs
Developmental,
reproductive,
subacute,
subchronic,
chronic
Lowest NOAEL
and NOAEL
corresponding
to lowest
LOAEL
Besides the NOAELs as reported in studies,
also NOAELs multiplied by species and
study speciﬁc factors to give anticipated
initial doses. For comparison, also Munro’s
time extrapolation was used.
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NOAEL decreases from 2661 (97.5th/2.5th percentile ratio) to 924.
From the Munro database (Munro et al., 1996) (downloaded
from http://www.efsa.europa.eu/de/supporting/pub/159e.htm),the Cramer class III compounds (dataset NMun(cl3) with 437 com-
pounds) and the Cramer class III compounds except organophos-
phates and carbamates (dataset NMun(cl3)nO with 410
compounds) were extracted and compared with the datasets NM
Fig. 1. Lowest NOAEL distributions selected according the criteria of (Munro et al.,
1996). The solid line depicts the distribution of lowest NOAELs from PSMTOXDB
(NMnO) selected and transformed according to the criteria of Munro. The short-
dashed line depicts the Cramer class III compounds in the Munro database
(NMun(cl3)nO). In both distributions, organophosphates and carbamates were
excluded. The inserted plot magniﬁes the area around the 5th percentile of the
cumulative distributions.
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datasets contain the lowest NOAELs of PSMTOXDB including and
excluding organophosphates/carbamates, respectively. NM and
NMnO were generated by applying Munro’s selection criteria to
PSMTOXDB, i.e. mainly excluding dog studies and subacute studies.
Furthermore, as done by Munro and colleagues, NOAEL of sub-
chronic studies (but not for multi-generation studies) were divided
by 3 to extrapolate to a hypothetic chronic NOAEL. In Munro’s
paper (Munro et al., 1996) it is stated, that a signiﬁcant proportion
of the subchronic NOAELs were lower than chronic NOAEL. It is
however not clear from the publication, whether all subchronic
NOAELs in the reference database were divided by 3 and then
the lowest NOAEL per compound was identiﬁed or whether the
lowest NOAELs per compound were identiﬁed ﬁrst and then, if a
lowest NOAEL for a compound was a subchronic NOAEL, was
divided by 3. For the present analysis, it is assumed that Munro
and colleagues divided all subchronic NOAELs by 3 and only then
performed the selection of lowest NOAELS. Therefore, in
PSMTOXDB all subchronic NOAELs were also divided by 3. It is
assumed that the pairs of subsets NMun(cl3) and NM on one side
and NMun(cl3)nO and NMnO on the other side were generated
on different databases (Munro’s database and PSMTOXDB, respec-
tively) but by applying similar selection criteria.
The 5th percentile of the empirical NOAEL distributions are 0.05
and 0.22 for NM and NMnO and for NMun(cl3) and NMun(cl3)nO
the values are 0.20 and 0.30. The 4-fold difference between NM
and NMun(cl3) is explained mainly by the different proportions
of organophosphates and carbamates (among the most toxic com-
pounds in PSMTOXDB) in the two datasets. In PSMTOXDB, the pro-
portion of organophosphates and carbamates is approximately 14%
and only 6% in the Munro database. It is assumed that the higher
the proportion of the highly toxic organophosphates and carba-
mates is in a distribution, the lower the 5th percentile would be.
This is supported by the fact that the 4-fold difference between
the 5th percentiles of NM and NMun(cl3) decreases to a less than
twofold difference if organophosphates and carbamates are
excluded (NMnO and NMun(cl3)nO).
Although the differences in the 5th percentiles of NMnO and
NMun(cl3)nO are less than twofold, the shapes of the cumulative
distributions are signiﬁcantly different (Fig. 1). The NMun(cl3)nO
dataset seems to contain more compounds with relatively low tox-
icity compared to MNnO. This is also illustrated by the difference in
the 97.5th/2.5th percentile ratios. NMnO NOAELs are within a
range of less than 3 orders of magnitude whereas NMun(cl3)nO
NOAELs cover a range of more than 4 orders of magnitude.
Another explanation might be that the Munro database includes
compounds with relatively few toxicological studies. As will be dis-
cussed later this shifts lowest NOAEL distributions to higher
values.
Using the Munro criteria on PSMTOXDB (NMnO) results in a
lowest NOAEL distribution virtually indiscernible from the distri-
bution derived by including studies of all exposure durations, of
all species and not using exposure duration standardization factors
(NnO) (data not shown). The effects of two major parameters on
lowest NOAEL distributions in the Munro criteria neutralize each
other. First, the exclusion of shorter than subchronic studies and
all dog studies shifts the Munro lowest distributions to higher val-
ues whereas the application of the exposure duration standardiza-
tion factor (division of subchronic NOAELs by 3) shifts it to lower
values.
3.3. Effect of dose spacing
It is reasonable to assume that the wider the dose spacing in
studies is the wider NOAELs and LOAELs scatter around the toxico-
logical threshold. Therefore, heterogeneity in dose spacing ofstudies may have an effect on NOAEL and LOAEL distributions
and hence on related analyses. Recently, it was demonstrated that
the heterogeneity in dose spacing of studies inﬂuences NOAEL dis-
tributions and thereby inﬂuences statistical analyses of the effects
of different exposure durations on NOAEL (Zarn et al., 2013). In the
present analyses, the dose spacing also signiﬁcantly affects lowest
NOAEL distributions. For the NnO distribution, the 5th percentile is
0.22 mg/kg bw per day. Selecting lowest NOAELs only from studies
with dose spacing68 (N8nO) increases the 5th percentile by 79% to
0.40 mg/kg bw per day and the 5th percentile for N4nO by 123% to
0.50 mg/kg bw per day (Table 4 and Fig. 2).
The shift of lowest NOAEL distributions to higher values as a
consequence of applying dose spacing values as cut off criterion
is signiﬁcantly more pronounced than for the corresponding
LOAEL distributions (Fig. 3).
The 5th percentiles of LOAELs of the N8nO and N4nO distribu-
tions increase only by 25% and 35%, respectively, compared to
NnO. This indicates that in a fraction of the studies (predominantly
in the chronic studies) the dose levels expected to give a NOAEL
(based on ﬁndings in preceding shorter-term studies) were chosen
conservatively low by the study directors to ensure that a NOAEL is
achieved at all. Therefore, lowest NOAEL distributions not account-
ing for the dose spacing provide overly low lowest NOAEL
distributions.3.4. NOAELs related to lowest LOAELs
As it was found that lowest NOAEL distributions are sensitive to
the heterogeneity of dose spacing in the underlying dataset but
that corresponding LOAEL distributions are quite insensitive, an
alternative approach to investigate and to minimize the inﬂuence
of dose spacing was evaluated. Instead of selecting the lowest
NOAELs per compound, the lowest LOAELs were identiﬁed and
then the corresponding NOAELs were used for lowest NOAEL dis-
tributions. By this selection of lowest NOAEL distributions, the
5th percentile of N-LnO (selection of NOAELs corresponding to low-
est LOAELs) is increased by 26% to 0.28 mg/kg bw per day com-
pared to 0.22 mg/kg bw per day in the NnO distribution (direct
Fig. 2. Inﬂuence of dose spacing on lowest NOAEL distributions from PSMTOXDB. In
all lowest NOAEL distributions, organophosphates and carbamates were excluded.
The solid line depicts the lowest NOAEL distribution without study selection
regarding dose spacing (NnO). The short-dashed line depicts the lowest NOAEL
distribution of studies with dose spacing 68 (N8nO). The long-dashed line
represents the lowest NOAEL distribution of studies with dose spacing 64
(N4nO). The inserted plot magniﬁes the area around the 5th percentile of the
cumulative distributions.
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preselected for dose spacing 68, the effect is smaller. The 5th per-
centile of N-L8nO is increased by 12% to 0.45 mg/kg bw per day
compared to 0.40 mg/kg bw per day in N8nO. These upward shifts
in NOAEL distributions selected on lowest LOAELs were not pro-
nounced enough to attain statistical signiﬁcance (Mann
Whitney-U Test, p 0.05). This analysis shows that NOAEL selection
based on lowest LOAELs only partly minimizes the distortive
effects of NOAELs of studies with high dose spacing on NOAELFig. 3. Inﬂuence of dose spacing on LOAEL distributions from PSMTOXDB. For
LOAEL distributions, the LOAELs related to the lowest NOAELs were used. In all
LOAEL distributions, organophosphates and carbamates were excluded. The solid
line depicts the LOAEL distribution without study selection regarding dose spacing
(LnO). The short-dashed line depicts the LOAEL distribution of studies with dose
spacing 68 (L8nO). The long-dashed line represents the NOAEL distribution of
studies with dose spacing 64 (L4nO). The inserted plot magniﬁes the area around
the 5th percentile of the cumulative distributions.distributions. However, a combination of both methods, extracting
NOAELs corresponding to lowest LOAELs from studies preselected
for dose spacing 68, minimizes the effect of dose spacing and war-
rants that the lowest LOAEL (not necessarily coming from the same
study with the lowest NOAEL) was caught.
3.5. Standardization method for NOAEL and LOAEL from different
study types
Recently, it was demonstrated that extending the duration of
exposure of rodent toxicity studies beyond 4 weeks does not statis-
tically signiﬁcantly lower NOAELs and LOAELs if study design
parameters are accounted for (Zarn et al., 2011). This suggests that
even a 4-week dosing period is capable of approximating the
threshold of toxicity as reliably as a chronic study. Although
extended exposure duration indeed might increase the severity
of effects beyond 4 weeks at the LOAEL identiﬁed in a subacute
study, the LOAEL itself is not further lowered. In certain study
designs the dose is applied either by providing feed at constant
compound concentrations or by capsule or gavage without regular
dose adjustment accounting for the constant dose decrements
related to the body weight increase (Zarn et al., 2013). In such
study designs, the NOAEL reported is an average over time within
a constantly decreasing dose curve. If the dose in a study was con-
stant over time, the average dose could be seen as the expected
value of the random variable dose. However, within a dose curve
constantly decreasing due to body weight increase, the average
dose over time is not an approximation of the expected value of
the dose but rather a mathematical measure without biological
justiﬁcation. Therefore, to account for the toxicological signiﬁcance
of the early exposures and to make NOAELs and LOAELs from dif-
ferent study designs and durations comparable, the NOAELs and
LOAELs were standardized to the initial dose the animals received
in the respective studies. In principle, this is the opposite of the
procedure used by Munro (Munro et al., 1996) and others where
NOAELs of subchronic studies (average doses over subchronic
phase) were divided by a default factor to extrapolate to an
expected chronic NOAEL (average doses over chronic phase).
In Fig. 4 the effect of standardizing NOAELs to the initial dose at
the beginning of the respective study is exempliﬁed with the low-
est NOAEL distribution and the standardized lowest NOAEL distri-
bution. The standardizing of NOAELs in the lowest NOAEL
distribution N8nOs increases the 5th percentile by 24% to
0.50 mg/kg bw per day and the 97.5th/2.5th percentile ratio is
hardly changed. This effect of standardizing the reported NOAEL
to the initial dose on the 5th percentiles and the 97.5th/2.5th per-
centile ratios is consistently seen (Table 4) in lowest NOAEL distri-
butions and the effect was statistically signiﬁcantly in all cases
(Mann Whitney-U Test, p = 0.05).
3.6. Weighting of NOAELs
All TTC analyses are based on NOAEL distributions using the
lowest NOAELs identiﬁed for the compounds of interest but the
comprehensiveness of the databases used in these analyses varies.
Therefore, it is difﬁcult to assign differences in the outcome of
analyses from different databases to true chemical group-speciﬁc
different toxicities. As every additional study for a given compound
either lowers the currently lowest NOAEL or is above the currently
lowest NOAEL and hence does not change it, a growing database
for a given compound by tendency lowers its lowest NOAEL.
Theoretically, the more extensive a database becomes by including
new studies for given compounds, by tendency the more the distri-
bution shifts to lower values. To investigate whether this plausible
assumption is veriﬁable by data, the N8nO distribution was ranked
according to the weighting values of the compounds and then
Fig. 4. Effect of weighting and standardization of NOAELs on lowest NOAEL
distributions from PSMTOXDB. In the three lowest NOAEL distributions,
organophosphates and carbamates were excluded and only studies with a dose
spacing 68 were used. The solid line depicts the lowest NOAEL distribution without
any further transformation (N8nO). The short-dashed line represents the distribu-
tion of weighted NOAELs (N8nOw) and the long-dashed line outlines the distribu-
tion of the standardized NOAELs (N8nOs). The inserted plot magniﬁes the area
around the 5th percentile of the cumulative distributions.
Fig. 5. Effect of weighting of NOAELs on lowest NOAEL distributions from
PSMTOXDB. The lowest NOAEL distribution N8nO (organophosphates and carba-
mates excluded, only studies with a dose spacing 68) was divided into two equal
fractions. In one fraction only NOAELs from compounds with high weighting scores
(N8nO_highweight, solid line) and in the other fraction only NOAELs from
compounds with low weighting scores (N8nO_lowweight, short-dashed line) were
included. The inserted plot magniﬁes the area around the 5th percentile of the
cumulative distributions.
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compounds with relatively few studies per compound and/or few
species tested (low weighting values) and N8nO_highweight is
the fraction of compounds with relatively many studies per com-
pound and/or many species tested (high weighting values). In
Fig. 5 the two sub-distributions N8nO_lowweight and
N8nO_highweight are depicted as the un-weighted NOAELs.
N8nO_highweight has a lower 5th percentile (0.31 versus
0.50 mg/kg bw per day) and a lower NOAEL span (97.5th/2.5th per-
centile ratio of 294 versus 827) than the N8nO_lowweight distribu-
tion. The two sub-distributions N8nO_lowweight and
N8nO_highweight were statistically signiﬁcantly different (Mann
Whitney-U Test, p = 0.05).
So, the broader the database of toxicity studies for given com-
pounds is, the more the NOAEL distribution shifts to lower values
and the tighter the distribution becomes. Because the extent of
the database affects lowest NOAEL distributions, all lowest
NOAEL subsets generated from PSMTOXDB by applying different
selection criteria were additionally transformed by weighting the
individual NOAELs with the categorized weighting factors (1, 3 or
12, respectively) derived for the respective compounds. Fig. 4
shows the effect of weighting on the cumulative NOAEL distribu-
tions. The 5th percentiles decrease by 15% (from 0.40 to 0.34 mg/kg
bw per day) and the range of NOAELs by 53% (97.5th/2.5th per-
centile ratio decreases from 631 to 300). The values reﬂecting the
shift (5th percentiles) and the shape of the distribution
(97.5th/2.5th percentile ratios) for the pair of cumulative lowest
NOAEL distributions N8nO and N8nOw are similar for other pairs
of weighted and un-weighted cumulative lowest NOAEL distribu-
tions (Table 4). The present method for weighting of the database
extent decreases the lower bound (2.5th and 5th percentile) little
to moderately and moderately the upper bound (97.5th percentile)
of cumulative lowest NOAEL distributions. It is concluded that
although the higher NOAELs are over-represented in un-weighted
distributions the 5th percentiles shifts downwards only by 10–
20% after weighting of the NOAELs for their underlying database.
Statistically, the small shifts between the pairs of distributions
attained statistical signiﬁcance (Mann Whitney-U Test, p = 0.05)
only in the pairs N8s vs. N8sw and N8nOs vs. N8nOsw andN-L8nOs vs. N-L8nOsw. Although the present method of weighting
was powerful enough to demonstrate the relevance of the database
available per compound within a given lowest NOAEL distribution,
it was weak in revealing the effect if un-weighted and weighted
lowest NOAEL distributions were compared. However, the 5th per-
centiles and the 97.5th/2.5th percentile ratios consistently
decrease in lowest NOAEL distributions if the NOAELs are
weighted.
The principle of favoring well documented lowest NOAELs over
poorly documented lowest NOAELs scientiﬁcally seems justiﬁed.
However, the implementation of such a system bears certainly
considerable arbitrariness as the ‘‘sensitivity’’ factors used directly
are related to the database per species available. And the database
per species available is related to the pesticide approval data
requirements.4. Summary
In current regulatory risk assessment practice, often a NOAEL is
the point of departure for derivation of health-based guidance val-
ues such as ADIs and TDIs. The NOAEL of a study is identical with
one of the doses pre-assigned during the study planning and is the
dose at which no statistically and/or biologically signiﬁcant
adverse effects are observed. For non-genotoxic compounds, it is
assumed that species-speciﬁc toxicological thresholds per com-
pound exist. For a given study, design parameters such as dose
spacing and statistical power determine how far a NOAEL is apart
from the toxicological threshold. The number of studies and the
number of species tested for a given compound are additional
determinants in the approximation of the lowest toxicological
threshold. However, since not all species can be tested with utmost
sensitivity and statistical power, regulatory toxicology studies
always are only attempts to approximate the toxicological thresh-
old for a compound with a reasonable effort. After decades of ani-
mal testing of chemicals there is a wealth of data available that can
be investigated for general principles regarding structure–activity
relationships as was done in the formation of the TTC concept over
the last decades. The present work focused on the effects of study
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to identify possible areas of improvement in the derivation of tox-
icological default values (such as TTC values) from scientiﬁcally
appropriate NOAEL distributions. For such a retrospective analysis,
differently designed study types and designs are very helpful as
only variability in parameters permits the identiﬁcation of the
inﬂuence of a parameter on an outcome of interest.
Before different parameters were investigated for their inﬂu-
ence on lowest NOAEL distributions, the PSMTOXDB was calibrated
to the Munro database to estimate where the PSMTOXDB data lie
relative to the Munro data. Using the 5th percentile as reference
point, the lowest NOAEL distribution (NMnO) of Cramer class III
compounds was less than twice as toxic but the NOAEL range
was more than tenfold smaller compared to Munro’s distribution
(NMun(cl3)nO). If the chemically very heterogeneous pesticides
are compared to Munro’s dataset it seems that ‘‘pesticides’’ in gen-
eral are signiﬁcantly but only slightly more toxic than other
Cramer class III compounds.
An important study design parameter is the dose spacing of
studies. Using only studies with restricted dose spacing (N4nO
and N8nO) shifts the lowest NOAEL distribution ca. twofold (5th
percentile) upwards. A similar but milder effect is achieved if not
the lowest NOAELs are selected but the NOAELs related to the low-
est LOAELs.
It was found recently that exposure duration has no signiﬁcant
effect on NOAEL beyond 4 weeks of exposure. Based on this ﬁnding
that a NOAEL essentially is revealed within the ﬁrst 4 weeks of a
study, the standardization method used by Munro to make
NOAELs from different study designs comparable was adapted.
Instead of standardizing subchronic NOAELs to chronic NOAELs
by division by 3, in all studies using non-constant dosing regimens
the doses were standardized to the initial dose animals received.
This takes into account that the initial high doses apparently con-
tribute more to the identiﬁcation of the NOAEL than the decreasing
doses observed in many study designs as exposure durations
increase. The standardization factors used are species and study
duration-speciﬁc values (Zarn et al., 2010, 2013). Using this stan-
dardization method shifts lowest NOAEL distributions by 10–50%
(e.g. NnO and NnOs) upwards.Fig. 6. Summary effect of selection criteria and transformations on lowest NOAEL
distributions (organophosphates and carbamates excluded) from PSMTOXDB. The
solid line depicts the lowest NOAEL distribution without speciﬁc study selection
criteria or transformations (NnO). The short-dashed line represents the distribution
of weighted and standardized NOAELs related to lowest LOAELs from studies with a
dose spacing 68 (N-L8nOsw). The inserted plot magniﬁes the area around the 5th
percentile of the cumulative distributions.The extent of the toxicological database available for the com-
pounds inﬂuences the NOAEL distributions. The lowest NOAEL dis-
tribution N8nO was divided into two fractions. N8nO_lowweight is
the fraction of compounds with a weaker underlying database (less
studies and/or species per compound) than the fraction
N8nO_highweight. It was found that the lowest NOAEL distribution
of N8nO_highweight was shifted downwards and that the distribu-
tion was tighter. Based on this ﬁnding the weighting system was
applied to all datasets. There was a consistent downward shift of
lowest NOAEL distributions if the lowest NOAELs of more intensely
studied compounds were higher weighted than lowest NOAELs of
less intensely studied compounds (e.g. N8nO and N8nOw).
However the effect of weighting clearly seen within a lowest
NOAEL distribution (N8nO segmented into N8nO_lowweight and
N8nO_highweight) was only weakly translated if a lowest NOAEL
distribution was transformed to a weighted distribution. The
weighting system might be amended by choosing other weighting
factors and by including for example weights for study types (not
only study number) and statistical power of the study (animal
number per dose group).5. Conclusion
The present analyses on lowest NOAEL distributions from
PSMTOXDB demonstrate effects of study design and
database-related parameters of varying potency on the
distributions.
If only studies were used with restricted dose spacing, a marked
upward shift of lowest NOAEL distributions was observed. By
trend, a similar but much less pronounced shift is achieved by
using NOAELs related to lowest LOAELs instead of directly selecting
lowest NOAELs.
A likewise upward shift of lowest NOAEL distributions comes
from standardization of NOAELs to the initial dose animals
received in the respective study. This standardization to the initial
dose seems justiﬁed as for a given compound no shift to lower
NOAELs is observed upon extension of exposure duration.
A lowest NOAEL distribution downward-shifting effect was
observed if the number of studies and species tested per compound
were allowed for. However, the performance of the weighting sys-
tem used is weak and might be improved. Additionally, the weight-
ing system might be severely distorted by several factors, e.g.
regarding species sensitivities because rats, dogs, mice and rabbits
are tested in quite different study types.
In conclusion, if databases of NOAELs are used for quantitative
analyses of chemical structure group-related NOAEL distributions,
clear selection criteria and transforming procedures allowing for
study design and database parameters might be necessary in case
that several studies per compound are available. In the present
work, the most prominent effect came from differences in dose
spacing between studies. Therefore, in databases including several
studies per compound, the most relevant NOAELs are the NOAELs
related to the lowest LOAELs from a dose spacing restricted subset.
Reasonable dose spacing cut off values should be assigned after
statistical evaluations of the database. To account for different
study designs and exposure durations, NOAELs might be standard-
ized to initial dose animals received at the beginning of the respec-
tive study. To account for differences in the extent of data per
compound, a weighting system might be applied to give different
weights to toxicologically differently investigated compounds.
In summary, for NOAELs of Cramer class III pesticides in
PSMTOXDB the 5th percentile of 0.22 mg/kg bw per day (NnO dis-
tribution, no speciﬁc selection criteria, no transformations)
increases more than twofold to 0.50 mg/kg bw per day in the more
speciﬁc N-L8nOsw distribution (Fig. 6).
500 J.A. Zarn et al. / Regulatory Toxicology and Pharmacology 72 (2015) 491–500As the parameters investigated here for their inﬂuence on
NOAEL distributions are not chemical group-speciﬁc but rather
related to study design/databases, the ﬁndings might be applicable
to NOAEL distributions of chemicals other than pesticides and also
to other Cramer classes
The results show that database and study design parameters
slightly inﬂuence NOAEL distributions and that current TTC values
are therefore affected only to a minor extent by these parameters
and can be considered reliable in that perspective.
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